Ll. Judd et Hs. Akiskal, Delineating the longitudinal structure of depressive illness: Beyond clinical subtypes and duration thresholds, PHARMACOPS, 33(1), 2000, pp. 3-7
Through the use of polysomnographic, epidemiologic, and prospective clinica
l follow-up studies, the authors document that the course of major depressi
ve disorder (MDD) is expressed by fluctuating symptoms in which depressive
subtypes included in official diagnostic systems do not represent discrete
disorders, but are stages along a dimensional continuum of symptomatic seve
rity. Depressive symptoms at the major, minor, dysthymic or otherwise subth
reshold levels are all integral components of the longitudinal clinical str
ucture of MDD with each symptom level representing a different phase of ill
ness intensity, activity and severity. Detailed analyses indicate that pati
ents are symptomatic 60% of the time, much of it at the minor, dysthymic or
subthreshold level. The symptomatic phases of illness activity are intersp
ersed sporadically with inactive phases, when patients are asymptomatic. Th
ese findings are pertinent to both clinical cohorts and community-based epi
demiologic samples. Each level of depressive symptom severity is associated
with significant psychosocial impairment; such impairment increases progre
ssively with each stepwise increment in symptom severity, When patients are
asymptomatic their psychosocial functioning returns to good or very good l
evels. Residual subthreshold symptoms in the course of MDD are associated w
ith high risk for early episode relapse and a significantly more chronic co
urse of illness, Asymptomatic recovery from MDD is associated with signific
ant delays in episode relapse and recurrence and a more benign course of il
lness. We submit that, as in the case of chronic medical conditions, the go
al of treating unipolar depressive illness should optimally be to return th
e patient to as asymptomatic a level as is feasible by all available therap
eutic means.